HomeANAB • NASDAQ
add
AnaptysBio Inc
Previous close
$20.40
Day range
$19.98 - $20.73
Year range
$12.21 - $41.31
Market cap
594.07M USD
Avg Volume
650.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 27.77M | 286.84% |
Operating expense | 14.13M | 14.52% |
Net income | -39.33M | 10.49% |
Net profit margin | -141.62 | 76.86% |
Earnings per share | -1.28 | 21.95% |
EBITDA | -27.39M | 34.84% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 339.94M | -4.15% |
Total assets | 422.05M | 4.00% |
Total liabilities | 388.03M | 8.37% |
Total equity | 34.02M | — |
Shares outstanding | 29.38M | — |
Price to book | 18.21 | — |
Return on assets | -15.20% | — |
Return on capital | -16.79% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -39.33M | 10.49% |
Cash from operations | -10.70M | 71.28% |
Cash from investing | 14.85M | -78.36% |
Cash from financing | -28.59M | -109.71% |
Net change in cash | -24.44M | -237.86% |
Free cash flow | 3.14M | 111.80% |
About
Founded
2005
Headquarters
Website
Employees
136
